Eli Lilly and Co
CNBC Daily Open: There’s the AI market, and then there’s ‘everything else’
Traders work on the floor of the New York Stock Exchange (NYSE) on Nov. 12, 2025 in New York City. Spencer Platt | Getty Images The divergence between the performance of the Dow Jones Industrial Average and Nasdaq Composite on Wednesday stateside reinforces the suggestion that there are two markets operating in the U.S.: one […]
Read More
CNBC Daily Open: An AI and ‘everything else’ market in play in the U.S.
Traders work on the floor of the New York Stock Exchange (NYSE) on Nov. 12, 2025 in New York City. Spencer Platt | Getty Images The divergence between the performance of the Dow Jones Industrial Average and Nasdaq Composite on Wednesday stateside reinforces the suggestion that there are two markets operating in the U.S.: one […]
Read More
What Anthropic’s $50 billion AI infrastructure investment means for these 3 portfolio stocks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks were mixed Wednesday as Wall Street hoped for an end to the government’s record-breaking shutdown. The House is set for a final vote in […]
Read More
Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data
A view shows a Novo Nordisk sign outside its office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on July 14, 2025. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. All […]
Read More
Stock futures little changed after Dow notches record high: Live updates
A trader works on the floor of the New York Stock Exchange. NYSE Stock futures were relatively flat Tuesday night following a session where investors sold off technology names and drove a rally in more risk-off parts of the market. Futures tied to the Dow Jones Industrial Average added 3 points points, or 0.01%. S&P […]
Read More
Novo Nordisk walked away from a $10 billion biotech deal — and investors aren’t sure if that’s smart or scary
Novo Nordisk has a lot on its plate — and it may not all be healthy. The pharmaceutical giant pulled out of its bidding war against rival Pfizer for clinical-stage biotech Metsera when the U.S. juggernaut matched its latest offer. Metsera accepted Pfizer’s $10 billion deal — significantly more than what Pfizer had initially offered […]
Read More
Week in review: The Nasdaq’s worst week since April, three trades, and earnings
It was a terrible start to November on Wall Street. The tech-heavy Nasdaq sank just over 3% in its worst weekly performance since early April. The S & P 500 fell 1.6% for the week. Both stock measures broke three-week winning streaks.This week’s market decline, which followed a strong October, can be chalked up to […]
Read More
These stocks are the most oversold in the selloff and could be due for a bounce
After quite a disappointing week for the broader market, several very beaten-down names in the S & P 500 could soon be due for a trading bounce, according to one popular technical metric. All three major U.S. indexes ended the week in the red, with the Nasdaq notching its worst week since April. Investors have […]
Read More
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Smith Collection | Archive Photos | Getty Images Obesity drug developer Metsera said on Friday that it had accepted Pfizer‘s $10 billion acquisition offer, in what could spell the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk that erupted over the last week. Pfizer had appeared to have […]
Read More
Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]
Read More